Take a deeper dive

Drug Development During COVID-19 Panel Discussion Recordings

In this panel discussion series, industry experts answer questions on how the drug development industry is being impacted by the global pandemic. Watch recordings of the live panel discussions by filling out the forms below:

Panel Discussion Part 1 | May 31, 2020

During the first 45-minute session, industry experts discussed:

  • Strategies for virtual drug development
  • An overview of current guidances from the FDA
  • Real examples of how drug development programs are adapting
  • How the industry may be impacted by a global recession and social distancing
Panel Discussion Recording 1

 

Panel Discussion Part 2 | April 14, 2020

During the second 1-hour session, industry experts discussed:

  • How labs are adjusting to the crisis
  • FAQs from our clients and colleagues
  • Regulatory impacts from a former FDA reviewer
  • The latest impacts on ongoing and planned clinical trials from a Phase 1 site
Panel Discussion Recording 2

 

Panel Discussion Part 3 | May 5, 2020

During the third 1-hour session, industry experts discussed:

  • Obstacles faced by many sponsors when developing treatments for diseases outside of COVID-19
  • Impacts of the pandemic on drug development programs, directly from sponsors
  • Trends our consultants are seeing in development from various clients
Panel Discussion Recording 3